1. Home
  2. PRCH vs GLUE Comparison

PRCH vs GLUE Comparison

Compare PRCH & GLUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Porch Group Inc.

PRCH

Porch Group Inc.

HOLD

Current Price

$8.48

Market Cap

962.0M

Sector

Technology

ML Signal

HOLD

Logo Monte Rosa Therapeutics Inc.

GLUE

Monte Rosa Therapeutics Inc.

HOLD

Current Price

$23.67

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRCH
GLUE
Founded
2012
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
962.0M
1.1B
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
PRCH
GLUE
Price
$8.48
$23.67
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
9
4
Target Price
$17.56
$29.50
AVG Volume (30 Days)
1.3M
2.7M
Earning Date
02-24-2026
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.27
0.25
Revenue
$442,483,000.00
$181,538,000.00
Revenue This Year
N/A
$84.02
Revenue Next Year
$17.06
N/A
P/E Ratio
$31.37
$93.93
Revenue Growth
N/A
1112.27
52 Week Low
$3.72
$3.50
52 Week High
$19.44
$25.77

Technical Indicators

Market Signals
Indicator
PRCH
GLUE
Relative Strength Index (RSI) 35.35 67.65
Support Level $9.09 $23.16
Resistance Level $9.97 $24.49
Average True Range (ATR) 0.47 1.54
MACD 0.02 0.53
Stochastic Oscillator 6.75 83.03

Price Performance

Historical Comparison
PRCH
GLUE

About PRCH Porch Group Inc.

Porch Group Inc is a vertical software company reinventing the home services and insurance industries. It has two reportable segments: The vertical Software segment provides software and services to home services companies. The Vertical Software segment software and services provide inspection, mortgage, and title companies on a subscription and transactional basis, several key businesses, including inspection software and services, title insurance software, mortgage software, moving services, mover and homeowner marketing, and measurement software for roofers. The insurance segment provides consumers with insurance and warranty products to protect their homes, earning revenue through premiums collected on policies, policy fees, and commissions. Majority revenue is from Insurance segment.

About GLUE Monte Rosa Therapeutics Inc.

Monte Rosa Therapeutics Inc is a biotechnology company that specializes in developing molecular glue degraders (MGDs), a class of small molecule drugs that leverage the body's natural protein destruction mechanisms to selectively degrade therapeutically-relevant proteins. Utilizing the QuEEN platform, the company employ artificial intelligence and proprietary experimental tools to identify target proteins for degradation by MGDs. With a diverse library of over 50,000 MGD molecules, their product candidate, MRT-2359, targets the translation termination factor protein GSPT1 for potential use in MYC-driven tumors. The company's focus lies in advancing its pipeline of MGDs, aiming to provide novel therapeutic modalities for various diseases.

Share on Social Networks: